What is the focus of the KIC Ventures Series A?
The focus of our Series A is to accelerate our global scale by expanding our majority-owned portfolio of revenue-generating spine companies. We have raised a $15M round for KIC Ventures and have already closed the first $5M. This capital supports our mission to move spine care from traditional hospital-based models to more efficient, physician-led outpatient surgery centers.
How does investment with KIC Ventures differ compared other firms ?
As a physician-led private equity firm, we do not participate in minority investments. We strictly acquire majority ownership in companies, allowing us to control development and production. We execute a sustainable "buy and hold" strategy, focusing on growing enterprise value through clinical excellence and commercial traction rather than chasing short-term exits or dividends.
What specific technologies are in the current portfolio?
Our portfolio consists of "hard" medical assets that we own and control, such as AxioMed—the only viscoelastic total disc replacement with 10+ years of clinical data. Our NANISX Interventational Spine Innovation platform has already trained over 500 physicians in "Interventional Spine Surgery," creating a significant headstart in the global outpatient market.
Why is this Series A structured for long-term retirement (IRA/401k) investors?
We prefer investments from retirement accounts because our strategies are built for the long term. By focusing on asset appreciation and the fundamental growth of our technologies, we offer a de-risked alternative to the volatile public markets. We prioritize building a legacy of sustainable value that aligns with the "hold" timeline of retirement planning.
What are the requirements for participating in the Series A?
The minimum investment is $30,000.
DISCLAIMER:
This presentation is subject to and conditioned upon the Investor’s (a) reviewing a Confidential Private Placement Memorandum; (b) executing a Subscription Agreement and Investor Questionnaire; (c) being qualified by the Issuer as an Accredited Investor under Regulation D. Investor shall pay no investment funds until all of the foregoing have occurred to the satisfaction of Company as the Issuer. This presentation does not take into account, nor does it provide any tax, legal or investment advice or opinion regarding the specific investment objectives or financial situation of any person. Company reserves the right to amend or replace the information contained herein, in part or entirely, at any time, and undertakes no obligation to notify the recipient thereof.